NBIS vs UNH: Which Is the Better Buy?
Side-by-side comparison of Nebius Group N.V. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Nebius Group N.V. · Technology
$217.99
+45.0% upside to fair value
Med Conviction
Grade B
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
NBIS has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NBIS |
UNH |
| Current Price |
$217.99 |
$375.21 |
| Fair Value Estimate |
$316.09 |
$481.06 |
| Upside to Fair Value |
+45.0%
|
+28.2%
|
| Market Cap |
$52.3B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
56.8x
|
15.0x
|
| Price / Sales |
38.6x
|
0.8x
|
| Price / FCF |
—
|
14.4x
|
| Revenue Growth YoY |
+454.0%
|
+0.4%
|
| Gross Margin |
58.6%
|
22.5%
|
| Operating Margin |
-49.3%
|
4.8%
|
| Return on Equity |
0.9%
|
14.6%
|
| Dividend Yield |
0% |
2.41% |
| FCF Yield |
—
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Nebius Group N.V. is an Amsterdam-based AI infrastructure company, formerly Yandex N.V., that builds end-to-end GPU cloud clusters, cloud platforms and developer tools for demanding AI workloads, alongside Toloka AI data solutions, TripleTen education and Avride autonomous driving. The business is growing explosively, with revenue up 454.0% year over year in the most recent quarter, and it has de…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
NBIS |
UNH |
| Zone Low |
$237.07 |
$360.80 |
| Zone High |
$268.68 |
$408.90 |
| In Buy Zone? |
Yes
|
Yes
|